Received Oct 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | — |
Late 2nd dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too long in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received on 2020). In APR-2025, the patient received the 2nd dose of Shingrix. In APR-2025, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: Late 2nd dose). The outcome of the drug dose administration interval too long was not applicable. Additional Information: GSK Receipt date: 02-OCT-2025 Patient stated got 1 shot of Shingrix in 2020 and forgot to get a second. She then got a second shot in April of this year 2025. Does she need another i know it says to not restart the schedule, but it's been 5 years. The HCP did not provide the specific dates for the vaccines, only said 1st dose in 2020 and 2nd dose in Apr 2025. The batch number was not provided and a request for this information has been made.